Drugs and biologicals

Ended Awarded

Contract number
HHSN26300287
Awardee
Awarding agency
Obligated
$5,381

Award facts

Contract value 100% obligated
$5,381.15 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Billerica, MA 01821, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Office of the Director, a civilian federal agency, to EMD Millipore Corp, a foreign-owned, for-profit manufacturer of laboratory products and services. The $5,381.15 contract is for the provision of drugs and biologicals, with an ultimate completion date of December 31, 2015. EMD Millipore Corp, which does business as Milliporesigma, is a subsidiary of Merck KGaA and has established itself as a critical supplier of laboratory technologies and consumables to numerous U.S. government research and testing institutions. The contract does not have a set-aside designation.

Quick answers

Who was awarded contract HHSN26300287?

HHSN26300287 was awarded to EMD Millipore Corp by Office of the Director (National Institutes of Health) on November 4, 2015.

How much is contract HHSN26300287 worth?

The government has obligated $5,381 on HHSN26300287.

Is contract HHSN26300287 an order under another contract?

Yes. HHSN26300287 is a BPA call under HHSN263199900051144B, a blanket purchase agreement.

Was contract HHSN26300287 competed?

The extent of competition for HHSN26300287 was competed under sap. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login